GANX
Gain Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| – | – | 7,822.5% | 4,342.1% | 5,883.4% | 145.7% | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| 4,012.2% | 3,840.7% | 7,822.5% | 4,342.1% | 5,979.2% | 20,878.2% | – | – | |
| 1,077.4% | 1,344.2% | 4,325.1% | 4,137.7% | 6,808.9% | 19,550.0% | – | – | |
| 5,089.7% | 5,184.9% | 12,147.5% | 8,479.8% | 12,788.1% | 40,428.3% | – | – | |
| -4,989.7% | -5,084.9% | -12,047.5% | -8,379.8% | -12,688.1% | -40,328.3% | – | – | |
| 254.6% | 49.7% | 655.6% | 71.4% | 176.6% | – | – | – | |
| -5,316.9% | -5,293.7% | -12,369.0% | -8,416.4% | -12,488.8% | -40,210.7% | – | – | |
| 47.5% | 17.2% | 18.6% | 2.4% | 66.4% | 143.7% | – | – | |
| -5,364.4% | -5,310.9% | -12,387.7% | -8,418.9% | -12,555.1% | -40,354.3% | – | – | |
| -4,986.1% | -5,078.7% | -12,014.3% | -8,407.0% | -12,443.0% | -40,059.2% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.